| Literature DB >> 30705529 |
Diego Delgado1, Ane Garate1, Hunter Vincent2, Ane Miren Bilbao3, Rikin Patel4, Nicolás Fiz3, Steve Sampson5, Mikel Sánchez1,3.
Abstract
Knee osteoarthritis (OA) is a degenerative process that slowly destroys the joints producing pain and loss of function, and diminishes the quality of life. Current treatments alleviate this symptomatology but do not stop the disease, being total knee arthroplasty the only definitive solution. Among the emerging treatments, Platelet-Rich Plasma (PRP) has shown promising results in the treatment of OA. However, to improve its effectiveness, it is necessary to approach this pathology targeting the whole joint, not only the cartilage, but including other tissues such as subchondral bone. The pathological processes that occur in the subchondral bone have influence of the cartilage loss, aggravating the disease. The combination of intraarticular infiltrations with intraosseous infiltrations regulates the biological processes of the tissues, reducing the inflammatory environment and modulating the overexpression of biomolecules that generate an aberrant cellular behavior. Although the first clinical results using this technique are promising, further research and developing adequate protocols are necessary to achieve good clinical results.Entities:
Keywords: Growth factors; Intraosseous injection; Osteoarthritis; Platelet-rich plasma; Subchondral bone
Year: 2018 PMID: 30705529 PMCID: PMC6349647 DOI: 10.1016/j.jcot.2018.09.017
Source DB: PubMed Journal: J Clin Orthop Trauma ISSN: 0976-5662